107 related articles for article (PubMed ID: 16322098)
1. The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptor.
Seoane S; Perez-Fernandez R
Mol Endocrinol; 2006 Apr; 20(4):735-48. PubMed ID: 16322098
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
3. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
4. Cellular expression levels of the vitamin D receptor are critical to its transcriptional regulation by the pituitary transcription factor Pit-1.
Seoane S; Ben I; Centeno V; Perez-Fernandez R
Mol Endocrinol; 2007 Jul; 21(7):1513-25. PubMed ID: 17456792
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
6. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
[TBL] [Abstract][Full Text] [Related]
7. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).
Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A
Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.
Sinkkonen L; Malinen M; Saavalainen K; Väisänen S; Carlberg C
Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722
[TBL] [Abstract][Full Text] [Related]
12. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.
Quack M; Carlberg C
J Mol Biol; 2000 Feb; 296(3):743-56. PubMed ID: 10677278
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development.
Perez-Fernandez R; Seoane S; Garcia-Caballero T; Segura C; Macia M
Curr Med Chem; 2007; 14(29):3051-8. PubMed ID: 18220741
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.
Alroy I; Towers TL; Freedman LP
Mol Cell Biol; 1995 Oct; 15(10):5789-99. PubMed ID: 7565732
[TBL] [Abstract][Full Text] [Related]
15. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
D'Ambrosio D; Cippitelli M; Cocciolo MG; Mazzeo D; Di Lucia P; Lang R; Sinigaglia F; Panina-Bordignon P
J Clin Invest; 1998 Jan; 101(1):252-62. PubMed ID: 9421488
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.
Saramäki A; Banwell CM; Campbell MJ; Carlberg C
Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
[TBL] [Abstract][Full Text] [Related]
20. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]